Bioventus Inc.
NASDAQ:BVS
11.59 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -96.738 | -213.391 | 9.586 | 14.722 | 8.113 | 4.443 | -34.111 | -12.9 | -22.367 |
| Depreciation & Amortization
| 57.365 | 66.803 | 34.875 | 28.643 | 30.316 | 29.238 | 33.078 | 28.82 | 24.458 |
| Deferred Income Tax
| -2.377 | -52.792 | -9.756 | -0.511 | -0.348 | -0.079 | -0.432 | -0.701 | -0.475 |
| Stock Based Compensation
| 2.722 | 17.585 | 19.844 | 10.103 | 10.844 | 14.325 | 3.325 | 2.355 | 0.576 |
| Change In Working Capital
| -3.181 | -14.532 | -13.277 | 15.308 | -13.572 | 2.852 | -10.647 | -12.006 | -16.405 |
| Accounts Receivables
| 10.055 | -18.022 | -20.052 | -3.941 | -14.909 | -12.13 | -11.266 | -0.217 | -11.094 |
| Inventory
| -5.991 | -18.618 | 3.183 | -0.528 | -1.427 | 3.256 | -5.729 | 10.649 | -3.718 |
| Accounts Payables
| -5.275 | 0.011 | 18.211 | 20.51 | 6.646 | 12.148 | 5.182 | 3.043 | -2.928 |
| Other Working Capital
| -1.97 | 22.097 | -14.619 | -0.733 | -3.882 | -0.422 | 1.166 | -25.481 | 1.335 |
| Other Non Cash Items
| 57.553 | 182.79 | 6.075 | 3.534 | 5.36 | -5.592 | 20.351 | 6.346 | 11.857 |
| Operating Cash Flow
| 15.344 | -13.537 | 22.991 | 71.799 | 40.713 | 45.187 | 18.92 | 15.109 | 2.749 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -7.362 | -11.52 | -7.37 | -20.672 | -8.342 | -6.061 | -7.442 | -20.83 | -6.356 |
| Acquisitions Net
| 34.675 | -104.841 | -262.87 | 0 | 0.43 | 0 | -51.459 | -10.546 | 0 |
| Purchases Of Investments
| 0 | 0 | -13.52 | 0 | 0 | 0 | -0.941 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 276.39 | 0 | 0.43 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -11.506 | -0.075 | -276.39 | 0.172 | 0.43 | -0.04 | -1.284 | -19.668 | -4.643 |
| Investing Cash Flow
| 15.807 | -116.436 | -283.76 | -20.5 | -7.912 | -6.101 | -60.185 | -31.376 | -10.999 |
| Financing Activities: | |||||||||
| Debt Repayment
| -26.925 | -45.038 | -166.203 | -59 | -199.581 | -5.25 | -23.675 | -177.088 | -3.537 |
| Common Stock Issued
| 0.778 | 5.822 | 107.572 | 0 | 0 | 0 | 50 | 0 | 0 |
| Common Stock Repurchased
| 0 | -3.352 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | -0.367 | -19.886 | -9.137 | -7.846 | -1.016 | -2.399 | -2.501 |
| Other Financing Activities
| -0.506 | 107.996 | -0.037 | 49.317 | 197.767 | -0.16 | 54.921 | 170.443 | 10.338 |
| Financing Cash Flow
| -26.653 | 62.076 | 273.371 | -29.569 | -10.951 | -13.256 | 31.246 | -6.645 | 6.801 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.629 | 0.521 | -0.228 | 0.589 | -0.104 | -0.16 | -0.805 | -1.428 | -0.514 |
| Net Change In Cash
| 6.778 | -67.376 | 12.374 | 22.319 | 21.746 | 25.67 | -10.824 | -24.34 | -1.963 |
| Cash At End Of Period
| 36.964 | 31.837 | 99.213 | 86.839 | 64.52 | 42.774 | 4.95 | 15.774 | 40.114 |